| David R. Cioffi, D.p.m. | |
|
816 Estelle Dr, Ste 2, Lancaster, PA 17601-2135 | |
| (717) 892-7214 | |
| (717) 892-7216 |
| Full Name | David R. Cioffi, D.p.m. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 816 Estelle Dr, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063695765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | SC002831L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David R. Cioffi, D.p.m. 816 Estelle Dr, Ste 2, Lancaster, PA 17601-2135 Ph: (717) 892-7214 | David R. Cioffi, D.p.m. 816 Estelle Dr, Ste 2, Lancaster, PA 17601-2135 Ph: (717) 892-7214 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, RHEI Pharmaceuticals has received the acceptance letter from the State Food and Drug Administration (SFDA) of China acknowledging all necessary documentation for the MuGard has been submitted and accepted.
Norovirus is the most common cause of viral epidemic gastroenteritis. About 18% of all gastroenteritis infections are caused by Norovirus affecting 267 million people worldwide every year. According to information of the Robert Koch-Institute more than 200.000 Norovirus-infections were registered in Germany during 2012 and 2013. The Centers for Disease Control and Prevention report up to 21 million Norovirus-infections per year in the USA.
Cancer patients are willing to undergo many tests to receive advanced experimental treatment in clinical trials, according to a new study by Mayo Clinic, Scottsdale Healthcare and the Translational Genomics Research Institute.
More children with juvenile rheumatoid arthritis are experiencing remission of their symptoms, thanks to new biological therapies, but the remission is not well-understood. A new study published today in Arthritis Research & Therapy provides the first genomic characterization of remission in juvenile rheumatoid arthritis patients.
An Allina Health study published in the current issue of the journal Applied Clinical Informatics showed that a significant number of diagnostic tests and procedures can be avoided if clinicians exchange health information with other health systems.
› Verified 3 days ago
Peter C Smith Dpm Podiatrist Medicare: Medicare Enrolled Practice Location: 300 Granite Run Dr, Suite 160, Lancaster, PA 17601 Phone: 717-560-4310 Fax: 717-560-3452 | |
Dr. Jeffrey Michael Witman, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1525 Oregon Pike, Suite 2101, Lancaster, PA 17601 Phone: 717-397-3770 Fax: 717-397-3771 | |
Dr. Pamela Sauer, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 208 Cool Creek Way, Lancaster, PA 17602 Phone: 703-727-8972 Fax: 717-327-4666 | |
Wintersteen Foot And Ankle Associates Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 996 E Orange St, Lancaster, PA 17602 Phone: 717-295-5550 | |
David Calderone, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 170 N Pointe Blvd, Lancaster, PA 17601 Phone: 717-299-4871 Fax: 717-391-2494 | |
Dr. Paula Mckain-toomey, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1950 Marietta Ave, Lancaster, PA 17603 Phone: 717-392-7986 |